ALZAMEND NEURO, INC.

Consensus Alzamend Neuro, Inc.

Stocks

ALZN

US02262M6057

Biotechnology & Medical Research

Market Closed - Nasdaq 02:00:00 01/09/2026 am IST			5-day change	1st Jan Change
1.600 ^USD	-3.61%		+3.23%	-12.09%

20/08	Alzamend Neuro Reports Resting-State Fmri Findings For Al001 Accepted For Poster Presentation At Neuroscience 2026	CI
18/08	Alzamend Neuro, Inc. Reports Phase 1/2A Lithium Imaging Data For AL001 At ISMRM Workshop	CI

Evolution of the Average Target: Alzamend Neuro, Inc.

Evolution of the Target Price: Alzamend Neuro, Inc.

Changes in Analyst Recommendations: Alzamend Neuro, Inc.

8c5.AsqBcdAQ4sqP0XcEeqODx4tQHDEA4eTsn2t1CkjNfck.TZqsBuZPuuf1oEJqSsy0qvhoV3lWj6a0ry8hPgaMN45bu_Y7_Wq1ld-UBA~3871173b4125b27110f7188e7276e1ea

Analysts' recommendations: Alzamend Neuro, Inc.

12/23/12	Maxim Initiates Alzamend Neuro at Buy With $1.50 Price Target	MT
27/21/27	Ascendiant Capital Adjusts Price Target on Alzamend Neuro to $8.25 From $8, Maintains Buy Rating	MT
01/21/01	Alzamend Neuro : Ascendiant Capital Initiates Alzamend Neuro at Buy Rating With $8 Price Target	MT

More recommendations

Other Biotechnology & Medical Research

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	ALZAMEND NEURO, INC.			-	-	+1,525%
	LONZA GROUP AG					+18.13%
	REVOLUTION MEDICINES, INC.					+21.02%
	IQVIA HOLDINGS INC.					+5.35%
	BEONE MEDICINES AG					+20.18%
	CELLTRION, INC.					+40.83%
	MEDPACE HOLDINGS, INC.					-2.05%
	ASCENDIS PHARMA A/S					+19.48%
	EUROFINS SCIENTIFIC SE					-0.02%
	CHARLES RIVER LABORATORIES INTERNATIONAL, INC.					-2.51%
	Average					+164.54%
	Weighted average by Cap.					+16.53%

See all sector performances

Analysts' Consensus

Sell

Consensus

Buy

Mean consensus

BUY

Number of Analysts

1

Last Close Price

1.600USD

Average target price

26.00USD

Spread / Average Target

+1,525.00%

High Price Target

26.00USD

Spread / Highest target

+1,525.00%

Low Price Target

26.00USD

Spread / Lowest Target

+1,525.00%

Analyst Consensus Detail

Consensus revision (last 18 months)

Stock Market
Stocks
ALZN Stock
Consensus Alzamend Neuro, Inc.

As early as today, start finding the best investment opportunities!